Your browser doesn't support javascript.
loading
Apremilast in a Japanese subgroup with Behçet's syndrome: Results from a Phase 3, randomised, double-blind, placebo-controlled study.
Takeno, Mitsuhiro; Dobashi, Hiroaki; Tanaka, Yoshiya; Kono, Hajime; Sugii, Shouji; Kishimoto, Mitsumasa; Cheng, Sue; McCue, Shannon; Paris, Maria; Chen, Mindy; Ishigatsubo, Yoshiaki.
Afiliación
  • Takeno M; Department of Allergy and Rheumatology, Nippon Medical School, Musashi Kosugi Hospital, Kanagawa, Japan.
  • Dobashi H; Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Kono H; Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
  • Sugii S; Department of Rheumatic Diseases, Tokyo Metropolitan Matsuzawa Hospital, Tokyo, Japan.
  • Kishimoto M; Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Cheng S; Amgen Inc., Thousand Oaks, CA, USA.
  • McCue S; Celgene Corporation, Summit, NJ, USA.
  • Paris M; The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Chen M; Amgen Inc., Thousand Oaks, CA, USA.
  • Ishigatsubo Y; Amgen Inc., Thousand Oaks, CA, USA.
Mod Rheumatol ; 32(2): 413-421, 2022 Feb 28.
Article en En | MEDLINE | ID: mdl-34894266

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Síndrome de Behçet Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Mod Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Síndrome de Behçet Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Mod Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Japón